Target intelligence / Profile preview

MT-ND2 pseudogene 19 (MTND2P19)

Target
MTND2P19
Molecular classification
Other (pseudogene)
01

Overview

MT-ND2 pseudogene 19 (MTND2P19) is a nuclear pseudogene similar to the mitochondrial gene MT-ND2, which encodes the NADH dehydrogenase subunit 2 of Complex I in the respiratory electron transport chain. As a pseudogene, MTND2P19 is not translated into a functional protein and is not currently recognized as a direct drug target, therapeutic receptor, or enzyme. There are no well-established biological functions, disease roles, clinical utilities, or interacting drugs associated with this pseudogene. In current research, some mitochondrial pseudogenes—including other MT-ND2 pseudogenes—have been analyzed in the context of differential expression in neurodegenerative diseases, but MTND2P19 specifically is not characterized in the biomedical literature[5]. Summary: MT-ND2 pseudogene 19 (MTND2P19) is a nuclear pseudogene and not a protein-coding gene or receptor. It is not a therapeutic target, has no established biological function, mechanism, or disease relevance, and may be incorrectly listed as a target. If you are looking for functionally relevant mitochondrial targets, consider the canonical MT-ND2 gene, which encodes the NADH dehydrogenase subunit 2, a core part of mitochondrial Complex I[1][2][3][5].

Other names
MTND2P19
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on MT-ND2 pseudogene 19 (MTND2P19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND2 pseudogene 19 (MTND2P19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call